TSPO PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia
Vontobel, D. S.; Lai, K. O.; Bacioglu, M.; Nolan, G.; Maddison, D. C.; Adamski, A.; Goddard, J.; Shapiro, N. L.; Crook, H.; Fryer, T.; Hong, Y.; Wijesinghe, S.; Aigbirhio, F.; Avezov, E.; Allinson, K. S. J.; Quaegebeur, A.; O'Brien, J. T.; Rowe, J. B.; Spillantini, M. G.; Malpetti, M.
Show abstract
Brain inflammation is a key feature of frontotemporal dementia (FTD). TSPO PET is widely used as an in vivo proxy for neuroinflammation, but whether the elevated signal reflects microglial, astrocytic, or vascular pathology is controversial. We paired ante mortem [11C]PK11195 TSPO PET with post mortem neuropathology in 10 individuals with FTD (5 FTLD-tau, 5 FTLD-TDP) and 5 controls, combining CD68 immunohistochemistry across 17 regions, multiplex immunofluorescence pairing TSPO with microglial/macrophagic (IBA1, CD68), astrocytic (GFAP) and endothelial (CD31) markers, and three-dimensional single-cell reconstruction. CD68 burden was elevated in FTD, concentrated in white matter, and correlated with regional TSPO PET binding across pathologies ({beta} = 8.40, P < 0.001). Only the CD68-TSPO co-localised fraction tracked the PET signal, with no TSPO upregulation per-cell. The elevated TSPO PET signal in FTD likely reflects an increased burden of lysosome-enriched CD68+ microglia, supporting TSPO PET as a microglial-burden biomarker in both FTLD-tau and FTLD-TDP.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Peripheral inflammatory markers relate to central inflammation and survival in syndromes associated with frontotemporal lobar degeneration 95%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 95%
- Glucose metabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease 95%
Similar papers in this journal
- Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD 94%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 94%
- Brain Vasculature Accumulates Tau and Is Spatially Related to Tau Tangle Pathology in Alzheimer's Disease 94%
Similar papers in this journal
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 95%
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology 95%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 95%
Similar papers in this journal
- Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and Dementia with Lewy bodies 94%
- Single-cell Spatial Proteomic Imaging for Human Neuropathology 93%
- Emergence of distinct and heterogeneous strains of amyloid beta as Alzheimer s disease progresses in Down syndrome 93%
Similar papers in this journal
- Distinctive Whole-brain Cell-Types Predict Tissue Damage Patterns in Thirteen Neurodegenerative Conditions 95%
- Resting-state alterations in behavioral variant frontotemporal dementia are related to the distribution of monoamine and GABA neurotransmitter systems 95%
- Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer's Disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.